Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Cash generated from core business operations
Percentile
P13
Within normal range
vs 3Y Ago
-2.9x
Contraction
Streak
2 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-25.04M | +24.3% |
| 2024 | $-33.07M | +30.1% |
| 2023 | $-47.34M | -647.6% |
| 2022 | $8.64M | +141.4% |
| 2021 | $-20.87M | +3.5% |
| 2020 | $-21.62M | -0.7% |
| 2019 | $-21.46M | -4.3% |
| 2018 | $-20.57M | +4.6% |
| 2017 | $-21.55M | -3.7% |
| 2016 | $-20.79M | - |